Drug Discovery Product Showcase

  1. An Inside Look At Cell Therapy Services And Support 3/25/2024

    “Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.

  2. The In Vitro Model Redefining Drug Discovery And Development 3/1/2024

    Learn about a solution for next-generation in vitro models that leverages cutting-edge organ-on-a-chip technology to emulate human biology with unparalleled accuracy compared to conventional models.

  3. Contract Research Services For Drug Discovery And Development 2/13/2024

    Understand and predict human response earlier in the drug development process, and harness the advantages of Organ-on-a-Chip technology without needing to invest in capital equipment or train personnel.

  4. DNA2.0 - Gene Optimization And Synthesis 2/13/2024

    ATUM is building on DNA2.0's reputation for rapid, reliable and accurate DNA synthesis. Using our proprietary GeneGPS® and VectorGPS® platforms we design constructs optimized to express in your system, whether that's a single gene in E. coli, a metabolic pathway in yeast or a complex bispecific antibody in mammalian cells.

  5. End-To-End Capabilities 8/17/2023

    We have the expertise, technologies, and state-of-the-art facilities at ElevateBio BaseCamp® to deliver cell and gene therapies from concept through commercialization, all under a single roof, right from the start.

  6. Single-Use System For Clinical And Commercial Production Of LNPs 7/21/2023

    Learn about a scalable, single-use platform with built-in automation and regulatory compliance that enables standardized manufacturing workflows for mRNA-LNP drug product production.

  7. Automated, Single-Use System For Clinical And Commercial LNP Production 7/21/2023

    The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.

  8. CHO Platform Service Package For Biopharmaceutical Cell Line Development 6/28/2023

    Learn how this CHO platform service package can help you rapidly progress from DNA to GMP cell bank (MCB | WCB) and overcome typical obstacles that can delay a first commercial manufacturing batch.

  9. Bioengineering Solutions Using A Fully Integrated Ecosystem 5/30/2023

    Find solutions to meet your gene, protein, antibody, or cell line needs using two gene synthesis platforms that enable the design of constructs optimized for maximal expression/yield in your system.

  10. Robust Cell Line Development With Leap-In Transposase® 5/15/2023

    Improve your cell line development and achieve high productivity, rapid timelines, low risk development, and robust genetic stability with an innovative platform.